13F

Stock

Grace Therapeutics, Inc.

GRCE · held by 23 managers

Reported value

$14.9M

Holders

23

+1 new · −0 exited

Holders’ est. mark

$239.8K

Price effect on 2 books still in the name

Largest holder

$4.08M

Nantahala Capital Management, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Nantahala Capital Management, LLC1.18M$4.08MHeld
AIGH Capital Management LLC907.2K$3.15MHeld
ADAR1 Capital Management, LLC642K$2.22MHeld
BANK OF AMERICA CORP /DE/494.7K$1.71M$238.9KAdded$238.9K
Vanguard424K$1.48MHeld
Cerity Partners LLC422.7K$1.46MHeld
Renaissance Technologies129.8K$449KHeld
Citadel42.3K$147.6KHeld
XTX Topco Ltd30.3K$105.6KHeld
MORGAN STANLEY25.4K$88K$893Added$82.5K
Stratos Wealth Partners, LTD.11.2K$38.7KHeld
NATIONAL BANK OF CANADA /FI/2.72K$9.37KHeld
Tower Research Capital LLC (TRC)1.95K$6.73KHeld
BNP PARIBAS FINANCIAL MARKETS600$2.08KHeld
ROYAL BANK OF CANADA543$2KHeld
Activest Wealth Management104$360Held
SBI Securities Co., Ltd.101$349Held
Steward Partners Investment Advisory, LLC41$142Held
GSA CAPITAL PARTNERS LLP13.8K$48Held
FLAGSHIP HARBOR ADVISORS, LLC2$7New
NBC SECURITIES, INC.2$6Held
Federation des caisses Desjardins du Quebec1$3Held
Motiv8 Investments LLC20$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.